Victory Capital Management Inc Synthetic Biologics, Inc. Transaction History

Victory Capital Management Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$1.9 - $2.9 $283 - $432	-149 Reduced 0.67%	22,035 $5,000
Q1 2022 May 04, 2022	BUY	$2.3 - $4.3 $7,286 - $13,622	3,168 Added 16.66%	22,184 $5,000
Q4 2021 Feb 07, 2022	SELL	$2.7 - $4.5 $1,598 - $2,664	-592 Reduced 3.02%	19,016 $5,000
Q3 2021 Nov 02, 2021	SELL	$4.3 - $5.8 $4,257 - $5,742	-990 Reduced 4.81%	19,608 $9,000
Q2 2021 Aug 03, 2021	SELL	$4.6 - $7.2 $1,177 - $1,843	-256 Reduced 1.23%	20,598 $12,000
Q1 2021 May 04, 2021	BUY	$5.0 - $11.7 $104,270 - $243,991	20,854 New	20,854 $14,000
Q2 2020 Aug 07, 2020	SELL	$2.8 - $5.7 $7,977 - $16,239	-2,849 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$2.7 - $6.1 $105 - $237	-39 Reduced 1.35%	2,849 $1,000
Q4 2019 Feb 04, 2020	BUY	$3.9 - $5.3 $167 - $227	43 Added 1.51%	2,888 $2,000
Q3 2019 Nov 12, 2019	BUY	$3.9 - $5.9 $11,095 - $16,785	2,845 New	2,845 $1,000

Ticker SYN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,844,100
Market Cap $9.51M
Description
Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.